245 related articles for article (PubMed ID: 18465465)
1. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia.
Subrahmanyam P; Balakrishnan C; Dasgupta B
Scand J Rheumatol; 2008; 37(3):239-40. PubMed ID: 18465465
[No Abstract] [Full Text] [Related]
2. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
Geissal ED; Wernick R
J Clin Rheumatol; 2010 Jun; 16(4):185-7. PubMed ID: 20414125
[TBL] [Abstract][Full Text] [Related]
3. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis.
Jabbarvand M; Fard MA
Ocul Immunol Inflamm; 2010 Jun; 18(3):216-7. PubMed ID: 20482401
[TBL] [Abstract][Full Text] [Related]
4. The development of trigeminal neuralgia related to auricular chondritis in a patient with rheumatoid arthritis-relapsing polychondritis and its treatment with etanercept. Description of the first case.
Pamuk ON; Harmandar F; Cakir N
Clin Exp Rheumatol; 2009; 27(1):128-9. PubMed ID: 19327242
[TBL] [Abstract][Full Text] [Related]
5. [Anti-cytokine and anti-lymphocyte monoclonal antibodies in the treatment of thyroid associated ophthalmopathy].
Komorowski J; Jankiewicz-Wika J; Siejka A; Lawnicka H; Stepień H
Pol Merkur Lekarski; 2007 Jun; 22(132):571-4. PubMed ID: 17874632
[TBL] [Abstract][Full Text] [Related]
6. Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?
Hernández MV; Ruiz-Esquide V; Gómez-Caballero ME; Gómez-Puerta JA; Cañete JD; Sanmartí R
Rheumatology (Oxford); 2011 Aug; 50(8):1523-5. PubMed ID: 21593064
[No Abstract] [Full Text] [Related]
7. Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis.
Lee HC; Tsai TF
J Am Acad Dermatol; 2011 May; 64(5):1006-7. PubMed ID: 21496717
[No Abstract] [Full Text] [Related]
8. Neuromeningeal tuberculosis in a patient with rheumatoid arthritis previously exposed to ineffective etanercept therapy and revealed by infliximab.
DaSilva V; Roux CH; Bernard E; Brocq O; Albert C; Chami H; Grisot C; Allam Y; Dellamonica P; Euller-Ziegler L
J Rheumatol; 2010 Feb; 37(2):471. PubMed ID: 20147485
[No Abstract] [Full Text] [Related]
9. Tumor necrosis factor inhibitors: following best practice.
White B
Manag Care; 2005 May; 14(5 Suppl):17-23. PubMed ID: 15962833
[No Abstract] [Full Text] [Related]
10. Infliximab in relapsing polychondritis.
de Barros AP; Nakamura NA; Santana Tde F; Motta JQ; Bianchi WA
Rev Bras Reumatol; 2010; 50(2):211-6. PubMed ID: 21125156
[TBL] [Abstract][Full Text] [Related]
11. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.
Mpofu S; Estrach C; Curtis J; Moots RJ
Rheumatology (Oxford); 2003 Sep; 42(9):1117-8. PubMed ID: 12923271
[No Abstract] [Full Text] [Related]
12. Sustained efficacy and safety of adalimumab in psoriasis treatment: a retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment.
Van L; Modi SV; Yang DJ; Hsu S
Arch Dermatol; 2008 Jun; 144(6):804-6. PubMed ID: 18559778
[No Abstract] [Full Text] [Related]
13. Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model.
Ceyhan ST; Onguru O; Fidan U; Ide T; Yaman H; Kilic S; Baser I
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):100-4. PubMed ID: 21035240
[TBL] [Abstract][Full Text] [Related]
14. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
Cazabon S; Over K; Butcher J
Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
[No Abstract] [Full Text] [Related]
15. Treatment of necrobiosis lipoidica with etanercept and adalimumab.
Zhang KS; Quan LT; Hsu S
Dermatol Online J; 2009 Dec; 15(12):12. PubMed ID: 20040262
[No Abstract] [Full Text] [Related]
16. Etanercept for toxic epidermal necrolysis.
Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G
Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541
[No Abstract] [Full Text] [Related]
17. Treatment of relapsing polychondritis with a TNF antagonist.
Carter JD
J Rheumatol; 2005 Jul; 32(7):1413. PubMed ID: 15996093
[No Abstract] [Full Text] [Related]
18. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus foliaceus treated with etanercept.
Gubinelli E; Bergamo F; Didona B; Annessi G; Atzori F; Raskovic D
J Am Acad Dermatol; 2006 Dec; 55(6):1107-8. PubMed ID: 17110226
[No Abstract] [Full Text] [Related]
20. A pilot study of etanercept treatment for pemphigus vulgaris.
Fiorentino DF; Garcia MS; Rehmus W; Kimball AB
Arch Dermatol; 2011 Jan; 147(1):117-8. PubMed ID: 21242406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
